Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pravastatin (pravachol) (1 trial)
sorafenib (nexavar) (1 trial)
Liver Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (2 total)